THE INFLUENCE OF ICER: COST-EFFECTIVENESS AND DECISION-MAKING FOR USA PAYERS

被引：0
|
作者：
Pikus, J. [1 ]
Mock, G. [1 ]
Chakwin, M. [1 ]
Lam, C. [1 ]
机构：
[1] Trinity, New York, NY USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA19
引用
收藏
页码：S507 / S507
页数：1
相关论文
共 50 条
  • [21] ICER: SIMILARITIES AND DIFFERENCES BETWEEN UK (ENGLAND) AND USA COST-EFFECTIVENESS WATCHDOGS
    Brough, A.
    Hunt, M.
    VALUE IN HEALTH, 2019, 22 : S808 - S809
  • [22] COST-EFFECTIVENESS OF UNIVERSAL HEPATITIS B IMMUNIZATION IN VIETNAM: APPLICATION OF COST-EFFECTIVENESS AFFORDABILITY CURVES IN HEALTH DECISION-MAKING
    Tu, H. A. T.
    de Vries, R.
    Woerdenbag, H. J.
    van Hulst, M.
    Postma, M. J.
    VALUE IN HEALTH, 2010, 13 (07) : A250 - A250
  • [23] When is it too expensive? Cost-effectiveness thresholds and health care decision-making
    Brouwer, Werner
    van Baal, Pieter
    van Exel, Job
    Versteegh, Matthijs
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2019, 20 (02): : 175 - 180
  • [24] USING COST-EFFECTIVENESS ANALYSIS FOR FORMULARY DECISION-MAKING - FROM THEORY INTO PRACTICE
    DETSKY, AS
    PHARMACOECONOMICS, 1994, 6 (04) : 281 - 286
  • [25] The impact on decision-making of changing cost-effectiveness of health technologies over time
    Pang, F
    Tolley, K
    VALUE IN HEALTH, 2005, 8 (06) : A193 - A193
  • [26] Cost-effectiveness estimates result in flawed decision-making in listing drugs for reimbursement
    West, R
    Borden, EK
    Collet, JP
    Rawson, NSB
    Tonks, RS
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2002, 93 (06): : 421 - 425
  • [27] When is it too expensive? Cost-effectiveness thresholds and health care decision-making
    Werner Brouwer
    Pieter van Baal
    Job van Exel
    Matthijs Versteegh
    The European Journal of Health Economics, 2019, 20 : 175 - 180
  • [28] Cost-effectiveness analysis of investment decision-making for environment protection by power plants
    Qi Jian-Xun
    Zheng Yan
    Fang Jun
    Niu Dong-Xiao
    2006 IEEE INTERNATIONAL CONFERENCE ON MANAGEMENT OF INNOVATION AND TECHNOLOGY, VOLS 1 AND 2, PROCEEDINGS, 2006, : 57 - +
  • [29] Streamlining biopharmaceutical decision-making: Designing for manufacturability, facility fit and cost-effectiveness
    Farid, Suzanne
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [30] Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia
    Loganathan, Tharani
    Ng, Chiu-Wan
    Lee, Way-Seah
    Hutubessy, Raymond C. W.
    Verguet, Stephane
    Jit, Mark
    HEALTH POLICY AND PLANNING, 2018, 33 (02) : 204 - 214
12345